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Abstract
Background:  Intra-articular  injections  of  local  anesthetics  are  commonly  used  to  enhance  post-
operative analgesia  following  orthopedic  surgery  as  arthroscopic  surgeries.  Nevertheless,  recent
reports of  severe  complications  due  to  the  use  of  intra-articular  local  anesthetic  have  raised
concerns.
Objectives:  The  study  aims  to  assess  use  of  vitamin  C  in  reducing  adverse  effects  of  the  most
commonly employed  anesthetics  --  ropivacaine,  bupivacaine  and  lidocaine  --  on  human  chon-
drocytes.
Methods: The  chondrocyte  viability  following  exposure  to  0.5%  bupivacaine  or  0.75%  ropiva-
caine or  1.0%  lidocaine  and/or  vitamin  C  at  doses  125,  250  and  500  M  was  determined  by
LIVE/DEAD assay  and  annexin  V  staining.  Expression  levels  of  caspases  3  and  9  were  assessed
using antibodies  by  Western  blotting.  Flow  cytometry  was  performed  to  analyze  the  generation
of reactive  oxygen  species.
Results:  On  exposure  to  the  local  anesthetics,  chondrotoxicity  was  found  in  the  order  ropi-
vacaine <  bupivacaine  <  lidocaine.  Vitamin  C  effectively  improved  the  reduced  chondrocyte
viability  and  decreased  the  raised  apoptosis  levels  following  exposure  to  anesthesia.  At  higher
doses, vitamin  C  was  found  efﬁcient  in  reducing  the  generation  of  reactive  oxygen  species  and
as well  down-regulate  the  expressions  of  caspases  3  and  9.
Conclusions:  Vitamin  C  was  observed  to  effectively  protect  chondrocytes  against  the  toxic  insult
of local  anesthetics  ropivacaine,  bupivacaine  and  lidocaine.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.∗ Corresponding author.
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Efeitos  comparativos  de  vitamina  C  sobre  os  efeitos  dos  anestésicos  locais
ropivacaína,  bupivacaína  e  lidocaína  em  condrócitos  humanos
Resumo
Justiﬁcaiva:  Injec¸ões  de  anestésicos  locais  por  via  intra-articular  são  comumente  usadas  para
melhorar a  analgesia  no  período  pós-operatório  de  cirurgia  ortopédica  como  artroscopias.  No
entanto, relatos  recentes  de  complicac¸ões  graves  devido  ao  uso  de  anestésico  local  por  via
intra-articular  causou  preocupac¸ões.
Objetivos:  O  objetivo  do  estudo  foi  avaliar  o  uso  de  vitamina  C  para  reduzir  os  efeitos  adversos
dos anestésicos  mais  comumente  usados  (ropivocaína,  bupivacaína  e  lidocaína)  sobre  condróc-
itos humanos.
Métodos:  A  viabilidade  dos  condrócitos  após  a  exposic¸ão  à  bupivacaína  a  0,5%  ou  ropivacaína
a 0,75%  ou  lidocaína  a  1,0%  e/ou  vitamina  C  em  doses  de  125,  250  e  500  M  foi  determinada
pelo ensaio  VIVO/MORTO  e  colorac¸ão  com  anexina  V.  Os  níveis  de  expressão  das  caspases  3  e  9
foram avaliados  usando  anticorpos  pela  técnica  Western  blot.  Citometria  de  ﬂuxo  foi  realizada
para analisar  a  gerac¸ão  de  espécies  reativas  ao  oxigênio.
Resultados:  Na  exposic¸ão  aos  anestésicos  locais,  condrotoxicidade  foi  encontrada  na  seguinte
ordem:  ropivacaína  <  bupivacaína  <  lidocaína.  A  vitamina  C  efetivamente  melhorou  a  reduc¸ão
da viabilidade  dos  condrócitos  e  diminuiu  os  níveis  elevados  de  apoptose  após  a  exposic¸ão  à
anestesia. Em  doses  mais  altas,  a  vitamina  C  foi  eﬁciente  para  reduzir  a  gerac¸ão  de  espécies
reativas ao  oxigênio  e  assim  regular  negativamente  a  expressão  das  caspases  3  e  9.
Conclusões:  Observamos  que  a  vitamina  C  foi  eﬁcaz  na  protec¸ão  dos  condrócitos  contra  a
agressão tóxica  dos  anestésicos  locais  ropivacaína,  bupivacaína  e  lidocaína.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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ocal  anesthetics  are  commonly  employed  in  various  clini-
al  settings  for  either  prevention  or  for  symptomatic  pain
elief.  During  orthopedic  practice,  they  are  administered  by
any  routes  as  spinal,  epidural  or  intra-articular  for  post-
perative  pain  relief,  or  as  a  modality  in  the  treatment
n  osteoarthritis.  Multiple  clinical  studies  have  shown  that
ntra-articular  injections  of  local  anesthetics  have  high  suc-
ess  rates  when  used  for  post-operative  analgesia.1--3
Concern  about  the  detrimental  effects  of  local  anesthet-
cs  came  to  note  when  multiple  case  studies  demonstrated
evere  toxicity  to  cartilage  and  chondrolysis  after  local
nesthetic  infusions  into  the  glenohumeral  joint  post
rthroscopy.4--8 As  the  evidence  of  chondrotoxicity  due  to
he  local  anesthetics  has  been  increasing,  investigations  on
he  use  of  other  substances  to  either  inhibit  or  reduce  the
oxicity  are  being  done.  In  orthopedic  surgeries,  adding  to
he  effects  of  local  anesthetics  limited  healing  potential  of
yaline  articular  cartilage  is  also  a  well-known  problem.9
Among  local  anesthetics  that  are  often  used  for  pain
elief,  lidocaine  and  bupivacaine  are  members  of  amide
roup,  but  the  duration  of  action  of  lidocaine  is  about
ne-half  as  that  of  bupivacaine.10 Ropivacaine  is  a  long  act-
ng  amino  amide  member  of  the  pipecoloxylidide  group  of
ocal  anesthetics  and  is  a  promising  substitute  for  bupiva-
aine  for  spine  anesthesia.1 However,  recent  studies  have
resented  the  deleterious  effects  of  these  anesthetics  on
hondrocytes.11--14 Lo  et  al.14 demonstrated  that  bupiva-
aine,  ropivacaine,  and  lidocaine  have  a  negative  effect  in
s
i
b dose-  and  duration-dependent  manner  on  the  viability  of
hondrocytes.
In  vitro  studies  have  shown  that  lidocaine  and  bupiva-
aine  can  have  cytotoxic  effects  on  neurons  and  myocytes,
ith  cell  death  occurring  by  both  necrosis  and  apoptosis.15,16
n  chondrocytes,  exposure  to  these  anesthetics  also  leads
o  cell  death  by  both  necrosis  and  apoptosis  in  a  dose-
nd  duration-dependent  manner.1,17 Fedder  et  al.18 reported
hat  exposure  to  ropivacaine,  lidocaine  and  bupivacaine
educed  the  viability  of  ﬁbroblasts  which  is  linked  to
eneration  of  reactive  oxygen  species  (ROS).  Apopto-
is  is  a  highly  regulated  process  distinct  from  necrosis
hat  occurs  in  response  to  trauma,  toxins,  cytokines,  and
athogens.19,20 Thus,  inhibition  of  chondrocyte  apoptosis  has
een  described  as  a  prospective  means  to  reduce  chondro-
yte  loss.20,21
Vitamins  have  been  considered  to  be  vital  for  living.
itamin  C,  an  exogenous  water-soluble  substance,22 is  a
ofactor  in  building  blood  vessels  and  takes  the  role  of  an
ntioxidant,23 by  acting  as  an  electron  donor  and  reduc-
ng  agent  and  thus  preventing  lipid,  protein  and  DNA
xidation.24 There  is  growing  recognition  of  the  impor-
ance  of  nutritional  factors  in  the  maintenance  of  bone
nd  joint  health.25 Bone  matrix  contains  over  90%  of  pro-
ein  as  collagen26 and  vitamin  C  is  an  essential  cofactor
or  collagen  formation  and  synthesis  of  hydroxyproline
nd  hydroxylysine.27 Therefore,  vitamin  C  may  help  in
trengthening  bone  and  prevent  fractures.  Experimentally
nduced  deﬁciency  of  vitamin  C  in  animals  leads  to  impaired
one  mass,  cartilage  and  connective  tissue.28 A  17-year
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follow-up  study  by  Sahni  et  al.29 demonstrated  that  vita-
min  C  supplementation  decreases  risk  of  hip  fracture  and
osteoporosis.  Thus  considering  the  effects  of  vitamin  C,  the
present  study  investigates  if  vitamin  C  inhibits  chrondocyte
loss  and  protects  cartilage  against  the  adverse  effects  of
local  anesthetics.
Methods
Chemicals  and  cells
Normal  human  chondrocytes  were  procured  from  Promo-
cell,  Germany  and  were  cultured  in  chondrocyte  growth
medium  (Promocell,  Germany)  under  standard  laboratory
conditions  (humidiﬁed  atmosphere  of  95%  air  and  5%  CO2,
37 ◦C).  Monolayer  culture  of  chondrocytes  has  long  been
used  as  a  method  for  assessing  in  vitro  cell  response  to
treatment.  The  cells  at  passage  5  were  seeded  at  a  den-
sity  of  103 cells/cm2 into  96-well  plates  and  cultured  until
75--80%  conﬂuence.  Upon  reaching  the  desired  conﬂuence,
the  cells  were  exposed  to  local  anesthetics.  All  chemicals
used  in  the  study  were  obtained  from  Sigma-Aldrich,  MO,
USA;  otherwise,  they  are  mentioned.
Anesthetic  exposure
Chondrocytes  were  exposed  for  1  h  to  1  mL  of  local  anes-
thetic  solutions:  0.5%  bupivacaine  or  0.75%  ropivacaine  or
1.0%  lidocaine,21,30 obtained  from  Sigma--Aldrich,  MO,  USA.
All  samples  were  treated  using  the  same  protocol.  Specif-
ically,  culture  medium  was  aspirated;  1  mL  of  0.9%  normal
saline  solution  or  anesthetic  were  added  to  each  well;  sam-
ples  were  incubated  in  5%  CO2 at  37 ◦C  for  60  min;  and  the
treatment  solution  was  aspirated  and  fresh  culture  medium
was  added.  Samples  were  returned  to  the  incubator  and
chondrocyte  viability  was  measured  24  h  later.  In  separate
experiments,  following  exposure  to  anesthesia,  the  cells
were  incubated  in  fresh  medium  supplemented  with  vita-
min  C  (125  or  250  or  500  M)  for  24  h,  following  which  the
cells  were  assessed  for  viability.
Apoptosis  analysis
Chondrocytes  exposed  to  anesthetics  and/or  vitamin  C  were
rinsed  with  PBS  and  used  for  cell  viability  analysis.  To  mea-
sure  apoptosis,  the  LIVE/DEAD  cell  viability  (LIVE/DEAD  cell
viability  kit,  Invitrogen)  assay  was  performed.  The  assay
determines  the  intracellular  esterase  activity  and  plasma
membrane  integrity  to  assess  the  viability  of  cells.  Chon-
drocytes,  treated  or  untreated  cells  with  anesthesia  and/or
vitamin  C,  were  stained  with  5  mol/L  ethidium  homodimer
and  5  mol/L  calcein-AM  and  incubated  at  37 ◦C  for  30  min.
The  cells  were  then  analyzed  under  a  Nikon  labophot-2  ﬂuo-
rescence  microscope.  Live  chondrocytes  retain  calcein-AM,
a  non-ﬂuorescent  polyanionic  dye,  and  produce  a  green  ﬂuo-
rescence  through  enzymatic  (esterase)  conversion.  Further,
ethidium  homodimer  enters  damaged  membranes  of  the
dead  cells  and  binds  to  nucleic  acids  thereby  yielding  a  red
ﬂuorescence.
C
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c
o31
Apoptosis  was  also  detected  by  measuring  the  loss  of
embrane  asymmetry  by  assessing  the  binding  properties
f  annexin  V.  The  binding  property  of  annexin  V  was  evalu-
ted  using  annexin  V  staining  kit  (Santa  Cruz  Biotechnology,
anta  Cruz,  CA,  USA).  Annexin  V  antibody  was  conjugated
ith  a  Fluorescein  isothiocyanate  (FITC)  dye.  Brieﬂy,  1  ×  106
ells  were  exposed  to  bupivacine  or  ropivacaine  or  lidocaine
or  1  h  following  treatment  with  vitamin  C,  or  only  those
xposed  to  anesthetics  were  subjected  to  annexin  V  stain-
ng.  The  cells  were  washed  in  PBS,  resuspended  in  100  L
f  binding  buffer  containing  a  FITC-conjugated  anti-annexin
 antibody,  and  then  analyzed  with  ﬂow  cytometer  (FACS
alibur,  BD  Biosciences).
estern  blotting
o  further  analyze  as  to  whether  caspase  activation  was
nvolved  in  the  initiation  of  apoptosis  following  exposure
o  local  anesthetics,  western  blot  analysis  was  performed
o  determine  the  expression  of  caspase-3  and  caspase-9
sing  respective  antibodies  (Cell  Signaling  Technology,  Dan-
ers,  MA,  USA).  For  isolation  of  total  cellular  proteins,  cells
ere  lysed  in  cell  lysing  buffer  (Cell  Signaling  Technology,
anvers,  MA,  USA)  and  processed  according  to  the  man-
facturer’s  instructions.  Proteins  were  then  fractionated
y  SDS-PAGE,  electrotransferred  to  nitrocellulose  mem-
ranes,  blotted  with  respective  antibodies  and  detected  by
nhanced  chemiluminescence  (GE  Healthcare).  The  band
ignals  of  other  proteins  were  normalized  to  those  of  -
ctin  using  anti--actin  at  1:2000  dilution  (Cell  Signaling
echnology,  Danvers,  MA,  USA).
etermination  of  reactive  oxygen  species  (ROS)
he  generation  of  intracellular  ROS  was  measured  by  ﬂow
ytometry  using  2′,7′-dichloroﬂuorescein  diacetate  (DCFH-
A)  staining.  DCFH-DA  is  a non-ﬂuorescent  compound  that
an  be  enzymatically  converted  to  DCF,  a  highly  ﬂuorescent
ompound,  in  the  presence  of  ROS.  Cells  following  exposure
o  anesthetic  and/or  vitamin  C  were  further  incubated  with
CFH-DA  (10  M)  for  30  min  at  37 ◦C  in  dark.  The  cells  were
hen  washed  twice  with  PBS  and  intensity  of  ﬂuorescence
as  measured  by  ﬂow  cytometry.31
tatistical  analysis
he  results  are  represented  as  mean  ±  SD.  Values  presenting
 <  0.05  are  considered  signiﬁcant  as  determined  by  one  way
nalysis  of  variance  (ANOVA).  The  analyses  were  performed
sing  version  17.0  SPPSS  package.
esults
itamin  C  improves  viability  of  chondrocytes
ollowing  anesthetic  exposurehondrocyte  viability  in  response  to  anesthetic  exposure  was
nalyzed  by  LIVE/DEAD  assay.  After  exposure  of  chondro-
yte  cultures  to  local  anesthetics  for  24  h,  chondrotoxicity
bserved  with  1%  lidocaine  was  almost  twice  greater  than
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eigure  1  Inﬂuence  of  vitamin  C  on  the  cell  viability  of  chon
 <  0.05  compared  with  control  as  determined  by  one  way  ANOV
.75%  ropivacaine  (Fig.  1).  There  was  a  marked  decrease  in
ell  viability  percentage  after  exposure  to  lidocaine,  ropiva-
aine  or  bupivacaine.  Comparing  equipotent  concentrations
f  ropivacaine  (0.75%)  and  bupivacaine  (0.5%),  the  cell  via-
ility  rates  were  signiﬁcantly  higher  24  h  after  treatment
ith  0.75%  ropivacaine  than  with  0.5%  bupivacaine.  Chon-
rotoxicity  was  more  pronounced  on  exposure  to  lidocaine
ollowed  by  bupivacaine.  Exposure  to  vitamin  C  following
nesthesia  resulted  in  a  signiﬁcant  (p  <  0.05)  improvement
n  cell  viability  percentage.  The  viable  chondrocyte  counts
ncreased  with  increasing  concentrations  of  vitamin  C.  The
00  M  concentration  caused  a  marked  raise  in  chondrocyte
iability  when  compared  to  lower  doses  (125  and  250  M).
Apoptosis  of  the  chondrocytes  following  anesthesia  expo-
ure  was  also  detected  by  measuring  the  loss  of  membrane
symmetry  by  annexin  V  staining.  The  apoptotic  cell  counts
ere  markedly  higher  (p  <  0.05)  following  anesthesia  expo-
ure.  Ropivacaine  at  0.75%  caused  considerably  lower
poptosis  as  compared  to  1%  lidocaine  and  0.5%  bupiva-
aine.  Incubation  with  vitamin  C  resulted  in  raised  viability
ercentage  with  decreased  apoptotic  cell  counts.  Vitamin  C
t  500  M  concentration  was  more  potent  than  lower  doses
n  reducing  apoptosis  after  exposure  to  local  anesthetics
Fig.  2).
itamin  C  suppresses  apoptosis  by  down-regulating
xpression  of  caspase-3  and  caspase-9
o  evaluate  the  possible  involvement  of  caspase  activation  in
nesthesia  induced  chondrotoxicity,  expression  of  caspase-
 and  caspase-9  was  determined  24  h  following  exposure
o  anesthesia.  One  hour  exposure  to  anesthetics  caused
p-regulation  of  caspase-3  and  caspase-9  in  the  order,
idocaine  >  bupivacaine  >  ropivacaine  (Fig.  3).  Thought  ropi-
acaine  at  0.75%  caused  raised  expressions  of  caspases,
t  was  found  to  be  a  non-signiﬁcant  raise  as  compared  to
ontrol  chondrocytes  not  exposed  to  anesthetics.  Neverthe-
ess,  1%  lidocaine  resulted  in  marked  enhancement  in  the
evel  of  expressions  indicating  caspase  cascade  activation  in
b
c
a
iytes.  Values  are  represented  as  mean  ±  SD;  n  =  6.  *Represents
poptosis.  Incubation  with  vitamin  C  for  24  h  markedly
educed  the  expression  of  caspases  in  a  dose-dependent
anner  that  was  in  line  with  the  results  of  the  LIVE/DEAD
ssay  and  annexin  V  staining.  Vitamin  C  at  250  and  500  M
ere  more  effective  in  down-regulating  the  expressions  of
aspases  3  and  9.
nﬂuence  of  vitamin  C  on  ROS  generation
e  determined  the  levels  of  ROS  by  ﬂow  cytometry
sing  2′,7′-dichloroﬂuorescein  diacetate  (DCFH-DA)  staining.
idocaine,  bupivacaine  and  ropivacaine  caused  a  marked
ncrease  in  ROS  production.  Lidocaine  caused  twice  as
uch  raised  ROS  generation  as  compared  to  ropivacaine
nd  almost  nearly  10%  more  than  bupivacaine.  This  raise
owever  was  suppressed  in  chondrocytes  incubated  with
itamin  C  as  against  cells  without  vitamin  C.  Treatment
ith  vitamin  C  signiﬁcantly  reduced  ROS  production  in  the
rder  125  <  250  <  500  M  (Fig.  4).  The  antioxidant  capacity
f  vitamin  C  could  have  been  responsible  for  the  marked
uppression  of  ROS.
iscussion
ntra-articular  injections  of  local  anesthetics  are  frequently
mployed  in  peri-operative  and  ambulatory  settings.32
ntra-articular  injections  of  local  anesthetics  enhance
ost-operative  analgesia.1,2,33 Lidocaine,  bupivacaine  and
opivacaine  are  amide-type  local  anesthetics.  Recent  pub-
ications  have  suggested  potential  adverse  effects  of  these
hree  local  anesthetics  on  articular  chondrocytes  in  vitro.1,11
Several  studies  have  described  the  detrimental  effects
f  local  anesthetics  on  chondrocyte  viability.  Chu  et  al.34
emonstrated  severe  toxicity  of  bupivacaine.  The  study
videnced  on  exposure  to  0.5%  bupivacaine  and  >99%  of  the
ovine  chondrocytes  were  found  to  be  killed  in  all  exposed
ultures.  Gomoll  et  al.35 reported  marked  histopathologic
nd  metabolic  changes  in  rabbit  shoulders  with  continuous
nfusion  of  0.25%  bupivacaine  with  and  without  epinephrine.
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Figure  2  Chondrotoxicity  induced  by  anesthetic  exposure:  (a)  0.5%  bupivacaine;  (e)  1%  lidocaine;  (i)  0.75%  ropivacaine.  Vitamin
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2Comparative  effects  of  vitamin  C  
local  anesthetics  --  lidocaine,  ropivacaine  and  bupivacaine
were  observed  to  induce  caspase  expression  levels  which
is  indicative  of  induction  of  apoptosis  in  the  chondrocytes
via  caspase  activation.  Perez-Castro  et  al.16 demonstrated
activation  of  caspase-3/-7  in  human  neuroblastoma  cells
following  incubation  with  lidocaine,  ropivacaine  and  bupi-
vacaine.  Nevertheless,  vitamin  C  suppressed  the  expression
of  caspases  3  and  9,  markedly  suggesting  its  anti-apoptotic
efﬁcacy.
The  mechanisms  that  lead  to  the  chondrotoxicity  of  local
anesthetics  are  not  completely  understood.  To  analyze  the
involvement  of  ROS-mediated  apoptosis,  ROS  generation  in
the  chondrocytes  was  assessed.  Marked  raise  in  ROS  gen-
eration  following  exposure  to  anesthetics  was  considerably
normalized  to  almost  normal  levels  on  incubation  of  chon-
drocytes  with  various  concentrations  of  vitamin  C.  This
could  be  due  to  the  potent  antioxidant  property  of  vitamin
C.  Vitamin  C  would  have  effectively  prevented  generation
of  ROS  and/or  neutralized  ROS.  However,  we  observed  a
striking  correlation  between  cell  viability,  caspase  expres-
sion  and  the  levels  of  ROS  production.  Park  et  al.37 have
shown  increased  ROS  concentration  correlating  with  cell
death  of  Schwann  cells  after  incubation  with  bupivacaine.
In  our  study,  ROS  concentrations  increased  upon  exposure  to
lidocaine  and  bupivacaine,  but  non-signiﬁcant  levels  were
observed  following  ropivacaine  exposure.  Similar  raise  in
ROS  generation  following  exposure  to  local  anesthetics  was
reported  by  Grishko  et  al.38
To  summarize,  we  have  shown  that  0.75%  ropivacaine,
though  toxic  to  human  chondrocyte  cells  following  60  min
exposure,  is  considerably  on  the  lower  toxic  range  as
against  0.5%  bupivacaine  and  1%  lidocaine.  Lidocaine  at
1%  concentration  presents  more  chondrotoxicity  among  the
anesthetics  studied.  Enhanced  ROS  production  evidenced
in  our  study  suggests  that  chondrotoxicity  could  be  pos-
sibly  due  to  ROS  and  ROS-mediated  apoptosis.  However,
incubation  with  vitamin  C  signiﬁcantly  offered  chondrocyte
protection,  which  we  could  possibly  be  attributed  to  its
antioxidant  capacity.
Conclusion
Vitamin  C  was  able  to  markedly  protect  the  condrocytes
against  the  toxic  effects  of  local  anesthetics  --  ropivacaine,
bupivacaine  and  lidocaine.
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